Neuropsychiatric disorders related to interferon and interleukins treatment

Metabolic Brain Disease

Volumn 24, Issue 1, 2009, Pages 55-68

  Myint, Aye Mu ^a   Schwarz, Markus J ^a   Steinbusch, Harry W M ^b   Leonard, Brian E ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Hepatitis C; Immune activation; Interferon; Interleukin; Neuropsychiatric side effects

Indexed keywords

2 AMINO 3 CARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE; 3 HYDROXYKYNURENINE; ALPHA INTERFERON; CARBOXYLYASE; CORTICOTROPIN; CYTOKINE; GLIAL FIBRILLARY ACIDIC PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; INTERFERON; INTERLEUKIN 2; INTERLEUKIN 6; KYNURENINE; KYNURENINE 3 MONOOXYGENASE; PICOLINIC ACID; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN; UNCLASSIFIED DRUG;

ANHEDONIA; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL TISSUE; ANXIETY; ANXIETY DISORDER; COGNITIVE DEFECT; CYTOKINE PRODUCTION; DEPRESSION; HEPATITIS C; HUMAN; HYPOMANIA; IMMUNOTHERAPY; MELANOMA; MENTAL DISEASE; MOOD; MOUSE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PSYCHOSIS; RAT; REVIEW; SEROTONIN RELEASE; SIDE EFFECT; SUICIDAL IDEATION;

ANIMALS; BRAIN; BRAIN DISEASES, METABOLIC; CYTOKINES; ENCEPHALITIS; HUMANS; INTERFERONS; INTERLEUKINS; KYNURENINE; MENTAL DISORDERS; TRYPTOPHAN;

ANIMALIA; HEPATITIS C VIRUS;

EID: 60449097147     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-008-9114-5     Document Type: Review

References (119)

1. V Arolt M Peters A Erfurth M Wiesmann U Missler S Rudolf H Kirchner M Rothermundt 2003 S100B and response to treatment in major depression: a pilot study Eur Neuropsychopharmacol 13 235 239
2. M Bannink D Fekkes AR Van Gool WH Kruit S Sleijfer B van der Holt AM Eggermont G Stoter MW Hengeveld 2007 Interferon-alpha influences tryptophan metabolism without inducing psychiatric side effects Neuropsychobiology 55 225 231
3. S Baron SK Tyring WR Fleischmann Jr DH Coppenhaver DW Niesel GR Klimpel GJ Stanton TK Hughes 1991 The interferons Mechanisms of action and clinical applications. Jama 266 1375 1383
4. DA Bender GM McCreanor 1985 Kynurenine hydroxylase: a potential rate-limiting enzyme in tryptophan metabolism Biochem Soc Trans 13 441 443
5. S Bonaccorso V Marino A Puzella M Pasquini M Biondi M Artini C Almerighi R Verkerk H Meltzer M Maes 2002 Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system J Clin Psychopharmacol 22 86 90
6. V Bozikas P Petrikis A Balla A Karavatos 2001 An interferon-alpha-induced psychotic disorder in a patient with chronic hepatitis C Eur Psychiatry 16 136 137
7. JD Bremner M Narayan ER Anderson LH Staib HL Miller DS Charney 2000 Hippocampal volume reduction in major depression Am J Psychiatry 157 115 118
8. WE Bunney Jr JM Davis 1965 Norepinephrine in depressive reactions. A review Arch Gen Psychiatry 13 483 494
9. L Capuron G Neurauter DL Musselman DH Lawson CB Nemeroff D Fuchs AH Miller 2003 Interferon-alpha-induced changes in tryptophan metabolism relationship to depression and paroxetine treatment. Biol Psychiatry 54 906 914
10. L Capuron CL Raison DL Musselman DH Lawson CB Nemeroff AH Miller 2003 Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy Am J Psychiatry 160 1342 1345
11. L Capuron G Pagnoni M Demetrashvili BJ Woolwine CB Nemeroff GS Berns AH Miller 2005 Anterior cingulate activation and error processing during interferon-alpha treatment Biol Psychiatry 58 190 196
12. JM Carlin EC Borden PM Sondel GI Byrne 1987 Biologic-response-modifier- induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures J Immunol 139 2414 2418
13. JM Carlin EC Borden PM Sondel GI Byrne 1989 Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes J Leukoc Biol 45 29 34
14. MG Carta MC Hardoy A Garofalo E Pisano V Nonnoi G Intilla G Serra C Balestrieri L Chessa C Cauli ME Lai P Farci 2007 Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy Clin Pract Epidemol Ment Health 3 22
15. EM Cassidy D Manning S Byrne E Bolger F Murray N Sharifi E Wallace M Keogan O V Keane 2002 Acute effects of low-dose interferon-alpha on serum cortisol and plasma interleukin-6 J Psychopharmacol 16 230 234
16. A Chiarugi M Calvani E Meli E Traggiai F Moroni 2001 Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages J Neuroimmunol 120 190 198
17. DR Cotter CM Pariante IP Everall 2001 Glial cell abnormalities in major psychiatric disorders: the evidence and implications Brain Res Bull 55 585 595
18. B Czeh M Simon B Schmelting C Hiemke E Fuchs 2005 Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment Neuropsychopharmacology 31 8 1616 1626
19. R De La Garza 2nd 2005 Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia Neurosci Biobehav Rev 29 761 770
20. R De La Garza 2nd GM Asnis E Pedrosa C Stearns AL Migdal JF Reinus R Paladugu S Vemulapalli 2005 Recombinant human interferon-alpha does not alter reward behavior, or neuroimmune and neuroendocrine activation in rats Prog Neuropsychopharmacol Biol Psychiatry 29 781 792
21. PL Delgado DS Charney LH Price GK Aghajanian H Landis GR Heninger 1990 Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan Arch Gen Psychiatry 47 411 418
22. PL Delgado LH Price HL Miller RM Salomon J Licinio JH Krystal GR Heninger DS Charney 1991 Rapid serotonin depletion as a provocative challenge test for patients with major depression: relevance to antidepressant action and the neurobiology of depression Psychopharmacol Bull 27 321 330
23. L Dell'Osso S Pini L Maggi P Rucci A Del Debbio M Carlini A Baldini G Ferrari E Manca E Beverini M Amore V Scarallo Q Semeraro M Brunetto F Bonino M Maj 2007 Subthreshold mania as predictor of depression during interferon treatment in HCV+ patients without current or lifetime psychiatric disorders J Psychosom Res 62 349 355
24. DE Dietrich U Hauser M Peters Y Zhang M Wiesmann M Hasselmann S Rudolf O Jungling H Kirchner TF Munte V Arolt HM Emrich S Johannes M Rothermundt 2004 Target evaluation processing and serum levels of nerve tissue protein S100B in patients with remitted major depression Neurosci Lett 354 69 73
25. G Dusheiko 1997 Side effects of alpha interferon in chronic hepatitis C Hepatology 26 112S 121S
26. J Dutcher 2002 Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma Oncology (Williston Park) 16 4 10
27. J Dutcher 2002 High-dose interleukin-2 in metastatic disease: renal cell carcinoma and melanoma Oncology (Williston Park) 16 3
28. JP Dutcher T Logan M Gordon J Sosman G Weiss K Margolin T Plasse J Mier M Lotze J Clark M Atkins 2000 Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study Clin Cancer Res 6 3442 3450
29. O Eton SS Legha AY Bedikian JJ Lee AC Buzaid C Hodges SE Ring NE Papadopoulos C Plager MJ East F Zhan RS Benjamin 2002 Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial J Clin Oncol 20 2045 2052
30. O Eton MG Rosenblum SS Legha W Zhang M Jo East A Bedikian N Papadopoulos A Buzaid RS Benjamin 2002 Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma Cancer 95 127 134
31. M Farkkila M Iivanainen R Roine L Bergstrom R Laaksonen ML Niemi K Cantell 1984 Neurotoxic and other side effects of high-dose interferon in amyotrophic lateral sclerosis Acta Neurol Scand 70 42 46
32. G Fattovich G Giustina S Favarato A Ruol 1996 A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon J Hepatol 24 38 47
33. JC Felger O Alagbe F Hu D Mook AA Freeman MM Sanchez NH Kalin E Ratti CB Nemeroff AH Miller 2007 Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression Biol Psychiatry 62 1324 1333
34. SL Fishman JM Murray FJ Eng JL Walewski S Morgello AD Branch 2008 Molecular and bioinformatic evidence of hepatitis C virus evolution in brain J Infect Dis 197 597 607
35. DM Forton JM Allsop J Main GR Foster HC Thomas SD Taylor-Robinson 2001 Evidence for a cerebral effect of the hepatitis C virus Lancet 358 38 39
36. DM Forton HC Thomas CA Murphy JM Allsop GR Foster J Main KA Wesnes SD Taylor-Robinson 2002 Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease Hepatology 35 433 439
37. DM Forton G Hamilton JM Allsop VP Grover K Wesnes O C Sullivan HC Thomas SD Taylor-Robinson 2008 Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study J Hepatol 49 316 322
38. EM Gal AD Sherman 1980 L-kynurenine: its synthesis and possible regulatory function in brain Neurochem Res 5 223 239
39. G Garcia-Pares C Domenech M Gil 2002 Psychosis induced by interferon-alpha Psychosomatics 43 428 429
40. E Gez R Rubinov D Gaitini S Meretyk LA Best O Native A Stein N Erlich A Beny J Zidan N Haim A Kuten 2002 Interleukin-2, interferon-alpha, 5-fluorouracil, and vinblastine in the treatment of metastatic renal cell carcinoma: a prospective phase II study: the experience of Rambam and Lin Medical Centers 1996-2000 Cancer 95 1644 1649
41. HJ Grabe N Ahrens HJ Rose C Kessler HJ Freyberger 2001 Neurotrophic factor S100 beta in major depression Neuropsychobiology 44 88 90
42. RS Grant V Kapoor 1998 Murine glial cells regenerate NAD, after peroxide-induced depletion, using either nicotinic acid, nicotinamide, or quinolinic acid as substrates J Neurochem 70 1759 1763
43. RS Grant H Naif M Espinosa V Kapoor 2000 IDO induction in IFN-gamma activated astroglia: a role in improving cell viability during oxidative stress Redox Rep 5 101 104
44. GJ Guillemin DG Smith SJ Kerr GA Smythe V Kapoor PJ Armati BJ Brew 2000 Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis Redox Rep 5 108 111
45. GJ Guillemin SJ Kerr GA Smythe DG Smith V Kapoor PJ Armati J Croitoru BJ Brew 2001 Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection J Neurochem 78 842 853
46. GJ Guillemin G Smythe O Takikawa BJ Brew 2005 Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons Glia 49 15 23
47. GJ Guillemin L Wang BJ Brew 2005 Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex J Neuroinflammation 2 16
48. GJ Guillemin CK Lim GA Smythe B Garner V Kapoor O Takikawa BJ Brew 2007 Characterization of the kynurenine pathway in human neurons J Neurosci 27 12884 12892
49. Hayaishi O (1980) Biochemical and medical aspects of tryptophan metabolism. Elsevier/North-Holland Biomedical, Amsterdam
50. G Hetzel O Moeller S Evers A Erfurth G Ponath V Arolt M Rothermundt 2005 The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment Psychopharmacology (Berl) 178 161 166
51. MP Heyes CL Achim CA Wiley EO Major K Saito SP Markey 1996 Human microglia convert l-tryptophan into the neurotoxin quinolinic acid Biochem J 320 Pt 2 595 597
52. C Hilmas EF Pereira M Alkondon A Rassoulpour R Schwarcz EX Albuquerque 2001 The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications J Neurosci 21 7463 7473
53. B Hu BD Hissong JM Carlin 1995 Interleukin-1 enhances indoleamine 2,3-dioxygenase activity by increasing specific mRNA expression in human mononuclear phagocytes J Interferon Cytokine Res 15 617 624
54. MM Husain WM McDonald PM Doraiswamy GS Figiel C Na PR Escalona OB Boyko CB Nemeroff KR Krishnan 1991 A magnetic resonance imaging study of putamen nuclei in major depression Psychiatry Res 40 95 99
55. M Iivanainen R Laaksonen ML Niemi M Farkkila L Bergstrom K Mattson A Niiranen K Cantell 1985 Memory and psychomotor impairment following high-dose interferon treatment in amyotrophic lateral sclerosis Acta Neurol Scand 72 475 480
56. JP Kim DW Choi 1987 Quinolinate neurotoxicity in cortical cell culture Neuroscience 23 423 432
57. YK Kim AM Myint BH Lee CS Han HJ Lee DJ Kim BE Leonard 2004 Th1, Th2 and Th3 cytokine alteration in schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 28 1129 1134
58. JW Koo RS Duman 2008 IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress Proc Natl Acad Sci USA 105 751 756
59. KR Krishnan WM McDonald PR Escalona PM Doraiswamy C Na MM Husain GS Figiel OB Boyko EH Ellinwood CB Nemeroff 1992 Magnetic resonance imaging of the caudate nuclei in depression Preliminary observations. Arch Gen Psychiatry 49 553 557
60. Z Kronfol DG Remick 2000 Cytokines and the brain: implications for clinical psychiatry Am J Psychiatry 157 683 694
61. SJ Larson KD Hartle TL Ivanco 2007 Acute administration of interleukin-1beta disrupts motor learning Behav Neurosci 121 1415 1420
62. BE Leonard 2007 Inflammation, depression and dementia: are they connected? Neurochem Res 32 1749 1756
63. FE Lotrich M Rabinovitz P Gironda BG Pollock 2007 Depression following pegylated interferon-alpha: characteristics and vulnerability J Psychosom Res 63 131 135
64. M Maes E Bosmans R De Jongh G Kenis E Vandoolaeghe H Neels 1997 Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression Cytokine 9 853 858
65. M Makino Y Kitano C Komiyama K Takasuna 2000 Human interferon-alpha increases immobility in the forced swimming test in rats Psychopharmacology (Berl) 148 106 110
66. A Mangoni 1974 The "kynurenine shunt" and depression Adv Biochem Psychopharmacol 11 293 298
67. K Mattson A Niiranen M Iivanainen M Farkkila L Bergstrom LR Holsti HL Kauppinen K Cantell 1983 Neurotoxicity of interferon Cancer Treat Rep 67 958 961
68. CA Meyers EA Obbens RS Scheibel RP Moser 1991 Neurotoxicity of intraventricularly administered alpha-interferon for leptomeningeal disease Cancer 68 88 92
69. CA Meyers RS Scheibel AD Forman 1991 Persistent neurotoxicity of systemically administered interferon-alpha Neurology 41 672 676
70. CL Miller IC Llenos JR Dulay S Weis 2006 Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder Brain Res 1073-1074 25 37
71. T Musso GL Gusella A Brooks DL Longo L Varesio 1994 Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes Blood 83 1408 1411
72. AM Myint YK Kim 2003 Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression Med Hypotheses 61 519 525
73. AM Myint BE Leonard HW Steinbusch YK Kim 2005 Th1, Th2, and Th3 cytokine alterations in major depression J Affect Disord 88 167 173
74. AM Myint YK Kim R Verkerk S Scharpe H Steinbusch B Leonard 2007 Kynurenine pathway in major depression: evidence of impaired neuroprotection J Affect Disord 98 143 151
75. AM Myint O S Mahony M Kubera YK Kim C Kenny A Kaim-Basta HW Steinbusch BE Leonard 2007 Role of paroxetine in interferon-alpha-induced immune and behavioural changes in male Wistar rats J Psychopharmacol 21 843 850
76. A Niiranen R Laaksonen M Iivanainen K Mattson M Farkkila K Cantell 1988 Behavioral assessment of patients treated with alpha-interferon Acta Psychiatr Scand 78 622 626
77. LK Nilsson KR Linderholm G Engberg L Paulson K Blennow LH Lindstrom C Nordin A Karanti P Persson S Erhardt 2005 Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia Schizophr Res 80 315 322
78. D Ongur WC Drevets JL Price 1998 Glial reduction in the subgenual prefrontal cortex in mood disorders Proc Natl Acad Sci USA 95 13290 13295
79. MN Perkins TW Stone 1982 An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid Brain Res 247 184 187
80. E Poutiainen L Hokkanen ML Niemi M Farkkila 1994 Reversible cognitive decline during high-dose alpha-interferon treatment Pharmacol Biochem Behav 47 901 905
81. LC Quarantini RA Bressan A Galvao S Batista-Neves R Parana A Miranda-Scippa 2007 Incidence of psychiatric side effects during pegylated interferon- alpha retreatment in nonresponder hepatitis C virus-infected patients Liver Int 27 1098 1102
82. G Rajkowska JJ Miguel-Hidalgo J Wei G Dilley SD Pittman HY Meltzer JC Overholser BL Roth CA Stockmeier 1999 Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression Biol Psychiatry 45 1085 1098
83. AZ Rohatiner PF Prior AC Burton AT Smith FR Balkwill TA Lister 1983 Central nervous system toxicity of interferon Br J Cancer 47 419 422
84. M Rothermundt V Arolt M Wiesmann U Missler M Peters S Rudolf H Kirchner 2001 S-100B is increased in melancholic but not in non-melancholic major depression J Affect Disord 66 89 93
85. K Saito Y Ohta Y Nagamura E Sasaki I Ishiguro 1990 Relationship between L-tryptophan uptake and L-tryptophan 2,3-dioxygenase activity in rat hepatocytes Biochem Int 20 71 80
86. M Salter CI Pogson 1985 The role of tryptophan 2,3-dioxygenase in the hormonal control of tryptophan metabolism in isolated rat liver cells. Effects of glucocorticoids and experimental diabetes Biochem J 229 499 504
87. U Satyanarayana BS Rao 1980 Dietary tryptophan level and the enzymes of tryptophan NAD pathway Br J Nutr 43 107 113
88. M Schaefer MA Engelbrecht O Gut BL Fiebich J Bauer F Schmidt H Grunze K Lieb 2002 Interferon alpha (IFNalpha) and psychiatric syndromes: a review Prog Neuropsychopharmacol Biol Psychiatry 26 731 746
89. JJ Schildkraut EK Gordon J Durell 1965 Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine J Psychiatr Res 3 213 228
90. ML Schroeter H Abdul-Khaliq A Diefenbacher IE Blasig 2002 S100B is increased in mood disorders and may be reduced by antidepressive treatment Neuroreport 13 1675 1678
91. R Schwarcz A Rassoulpour HQ Wu D Medoff CA Tamminga RC Roberts 2001 Increased cortical kynurenate content in schizophrenia Biol Psychiatry 50 521 530
92. MJ Schwarz S Chiang N Muller M Ackenheil 2001 T-helper-1 and T-helper-2 responses in psychiatric disorders Brain Behav Immun 15 340 370
93. L Schwieler S Erhardt 2003 Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid Neuropsychopharmacology 28 1770 1777
94. F Seifert T Struffert M Hildebrandt I Blumcke W Bruck D Staykov HB Huttner MJ Hilz S Schwab J Bardutzky 2008 In vivo detection of hepatitis C virus (HCV) RNA in the brain in a case of encephalitis: evidence for HCV neuroinvasion Eur J Neurol 15 214 218
95. YI Sheline M Sanghavi MA Mintun MH Gado 1999 Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression J Neurosci 19 5034 5043
96. PD Shepard B Joy L Clerkin R Schwarcz 2003 Micromolar brain levels of kynurenic acid are associated with a disruption of auditory sensory gating in the rat Neuropsychopharmacology 28 1454 1462
97. H Smedley M Katrak K Sikora T Wheeler 1983 Neurological effects of recombinant human interferon Br Med J (Clin Res Ed) 286 262 264
98. RS Smith 1991 The macrophage theory of depression Med Hypotheses 35 298 306
99. SA Smith FP Carr CI Pogson 1980 The metabolism of L-tryptophan by isolated rat liver cells. Quantification of the relative importance of, and the effect of nutritional status on, the individual pathways of tryptophan metabolism Biochem J 192 673 686
100. C Song BE Leonard 2005 The olfactory bulbectomised rat as a model of depression Neurosci Biobehav Rev 29 627 647
101. C Song DF Horrobin BE Leonard 2006 The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats Pharmacopsychiatry 39 88 99
102. C Song MS Manku DF Horrobin 2008 Long-chain polyunsaturated fatty acids modulate interleukin-1beta-induced changes in behavior, monoaminergic neurotransmitters, and brain inflammation in rats J Nutr 138 954 963
103. K Sudom NP Turrin S Hayley H Anisman 2004 Influence of chronic interleukin-2 infusion and stressors on sickness behaviors and neurochemical change in mice Neuroimmunomodulation 11 341 350
104. S Takahashi 1976 Reduction of blood platelet serotonin levels in manic and depressed patients Folia Psychiatr Neurol Jpn 30 475 486
105. S Takahashi 1977 Monoamine oxidase activity in blood platelets from manic and depressed patients Folia Psychiatr Neurol Jpn 31 37 48
106. L Tamam D Yerdelen N Ozpoyraz 2003 Psychosis associated with interferon alfa therapy for chronic hepatitis B Ann Pharmacother 37 384 387
107. MW Taylor GS Feng 1991 Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism Faseb J 5 2516 2522
108. D Telio S Sockalingam V Stergiopoulos 2006 Persistent psychosis after treatment with interferon alpha: a case report J Clin Psychopharmacol 26 446 447
109. LM Thomson RJ Sutherland 2006 Interleukin-1beta induces anorexia but not spatial learning and memory deficits in the rat Behav Brain Res 170 302 307
110. AD Valentine CA Meyers MA Kling E Richelson P Hauser 1998 Mood and cognitive side effects of interferon-alpha therapy Semin Oncol 25 39 47
111. K Viswanathan FS Dhabhar 2005 Stress-induced enhancement of leukocyte trafficking into sites of surgery or immune activation Proc Natl Acad Sci USA 102 5808 5813
112. K Weissenborn M Bokemeyer B Ahl D Fischer-Wasels K Giewekemeyer J van den Hoff H Kostler G Berding 2004 Functional imaging of the brain in patients with liver cirrhosis Metab Brain Dis 19 269 280
113. K Weissenborn J Krause M Bokemeyer H Hecker A Schuler JC Ennen B Ahl MP Manns KW Boker 2004 Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy J Hepatol 41 845 851
114. MC Wichers M Maes 2004 The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression J Psychiatry Neurosci 29 11 7
115. MC Wichers GH Koek G Robaeys R Verkerk S Scharpe M Maes 2005 IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity Mol Psychiatry 10 538 544
116. MC Wichers G Kenis C Leue G Koek G Robaeys M Maes 2006 Baseline immune activation as a risk factor for the onset of depression during interferon-alpha treatment Biol Psychiatry 60 77 79
117. MC Wichers G Kenis GH Koek G Robaeys NA Nicolson M Maes 2007 Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol J Psychosom Res 62 207 214
118. H Yasui K Takai R Yoshida O Hayaishi 1986 Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase: its possible occurrence in cancer patients Proc Natl Acad Sci USA 83 6622 6626
119. S Zalcman L Murray DG Dyck AH Greenberg DM Nance 1998 Interleukin-2 and -6 induce behavioral-activating effects in mice Brain Res 811 111 121